Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients
|ClinicalTrials.gov Identifier: NCT01760941|
Recruitment Status : Terminated (Slow accrual)
First Posted : January 4, 2013
Results First Posted : February 29, 2016
Last Update Posted : February 29, 2016
|Condition or disease||Intervention/treatment|
|Symptomatic Osseous Bone Lesions From Any Malignancy||Radiation: Radiation Therapy Other: Quality-of-Life Assessment Other: Survey Administration|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients|
|Study Start Date :||March 2013|
|Primary Completion Date :||January 2015|
|Study Completion Date :||June 2015|
Experimental: Treatment (radiation therapy)
This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400 flat rate, same-day consultation, simulation, and delivery of a single fraction of palliative radiation therapy for patients with symptomatic bony metastatic disease who are currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy will utilize "standard of care" techniques. A physician survey of feasibility will be conducted on the treatment day. Patient surveys will conducted on the day of treatment and at 2 weeks, 4 weeks, 2 months, 3 months, 4 months, 5 months, and 6 months after treatment.
Radiation: Radiation Therapy
Undergo standard of care radiation therapy
Other Names:Other: Quality-of-Life Assessment
The patient quality of life as measured by the ESAS-r; Edmonton Symptom Assessment System revised.Other: Survey Administration
The surveys consists of Radiation Therapy Worthfullness survey; BPI: brief pain inventory; NUS: narcotics usage survey.
- Feasibility of Treatment Delivery in the Same Day as Initial Evaluation [ Time Frame: Up to 6 months ]Patient evaluation will consist of surveys conducted at the time of treatment measured by the Radiation Oncologist Evaluation and Feasibility Assessments survey
- Evaluate the Treatment Influence on the Rate of Pain Stabilization and/or Reduction [ Time Frame: 2 weeks ]Evaluate the treatment influence on the rate of pain stabilization and/or reduction as measured by the validated BPI patient questionnaire.
- Evaluate the Treatment Influence on Patient Quality of Life [ Time Frame: 2 weeks ]Evaluate the treatment influence on patient quality of life as measured by the ESAS.
- Quantify the Percentage of Patients Receiving the Treatment Who Believe That the Treatment Was Worthwhile [ Time Frame: 6 months ]Quantify the percentage of patients receiving the treatment who believe that the treatment was worthwhile
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01760941
|United States, Virginia|
|Virginia Commonwealth University/Massey Cancer Center|
|Richmond, Virginia, United States, 23298|
|Principal Investigator:||Drew Moghanaki, MD, MPH||Virginia Commonwealth University|